This is the #covid19 paper for the week and perhaps show the way forward for #longcovid therapeutics with musculosceletal symptoms
https://buff.ly/40HfJbt
[#]Merck #Actelion #Roche, #Tide etc hold patents on P2X inhibitors (some of them are licensed for human use ex-US), e.g. see
https://buff.ly/4hERy4i
=> More informations about this toot | More toots from ChristosArgyrop@mastodon.social
One would like to test in a similar system whether other P2X antagonists provide similar or better efficacy If one of these previously approved drugs or investigational agents with human safety data works, then perhaps move it to trials for musculosceletal #longcovid?
=> More informations about this toot | More toots from ChristosArgyrop@mastodon.social
text/gemini
This content has been proxied by September (3851b).